The title compounds, C(32)H(28)N(10)O(4)· unknown solvent, (I), and C(32)H(28)N(10)O(4), (II), are pyrazine-2,3,5,6-tetra-carboxamide derivatives. In (I), the substituents are (pyridin-2-ylmeth-yl)carboxamide, while in (II), the substituents are (pyridin-4-ylmeth-yl)carboxamide. Both compounds crystallize in the monoclinic space group P2(1)/n, with Z' = 1 for (I), and Z' = 0.5 for (II). The whole mol-ecule of (II) is generated by inversion symmetry, the pyrazine ring being situated about a center of inversion. In (I), the four pyridine rings are inclined to the pyrazine ring by 83.9â (2), 82.16â (18), 82.73â (19) and 17.65â (19)°. This last dihedral angle involves a pyridine ring that is linked to the adjacent carboxamide O atom by an intra-molecular C-Hâ¯O hydrogen bond. In compound (II), the unique pyridine rings are inclined to the pyrazine ring by 33.3â (3) and 81.71â (10)°. There are two symmetrical intra-molecular C-Hâ¯O hydrogen bonds present in (II). In the crystal of (I), mol-ecules are linked by N-Hâ¯O and N-Hâ¯N hydrogen bonds, forming layers parallel to (10-1). The layers are linked by C-Hâ¯O and C-Hâ¯N hydrogen bonds, forming a three-dimensional framework. In the crystal of (II), mol-ecules are linked by N-Hâ¯N hydrogen bonds, forming chains propagating along the [010] direction. The chains are linked by a weaker N-Hâ¯N hydrogen bond, forming layers parallel to the (101) plane, which are in turn linked by C-Hâ¯O hydrogen bonds, forming a three-dimensional structure. In the crystal of compound (I), a region of disordered electron density was treated with the SQUEEZE routine in PLATON [Spek (2015 â¸). Acta Cryst. C71, 9-18]. Their contribution was not taken into account during refinement. In compound (II), one of the pyridine rings is positionally disordered, and the refined occupancy ratio for the disordered C(ar)-C(ar)-N(py) atoms is 0.58â (3):0.42â (3).
Crystal structures of N(2),N(3),N(5),N(6)-tetra-kis-(pyridin-2-ylmeth-yl)pyrazine-2,3,5,6-tetra-carboxamide and N(2),N(3),N(5),N(6)-tetra-kis-(pyridin-4-ylmeth-yl)pyrazine-2,3,5,6-tetra-carboxamide.
阅读:5
作者:Cati Dilovan S, Stoeckli-Evans Helen
| 期刊: | Acta Crystallographica Section E: Crystallographic Communications | 影响因子: | 0.500 |
| 时间: | 2017 | 起止号: | 2017 Jan 31; 73(Pt 2):300-305 |
| doi: | 10.1107/S205698901700127X | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
